Drug Shortage Report for FRAXIPARINE
Report ID | 149194 |
Drug Identification Number | 02236913 |
Brand name | FRAXIPARINE |
Common or Proper name | nadroparin calcium injection (0.3 mL) |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | DORMANT |
Active Ingredient(s) | NADROPARIN CALCIUM |
Strength(s) | 9500UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
Packaging size | 10 PF Syringe |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-03-01 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-03-02 |
Company comments | GR96389CA1 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-03-02 | English | Compare |
v4 | 2021-12-22 | French | Compare |
v3 | 2021-12-22 | English | Compare |
v2 | 2021-11-12 | French | Compare |
v1 | 2021-11-12 | English | Compare |
Showing 1 to 5 of 5